Navigation Links
IRIDEX Announces Fourth Quarter and Full Year 2008 Conference Call and Release Date
Date:3/3/2009

MOUNTAIN VIEW, Calif., March 3 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its fourth quarter and full year 2008 financial results after the market closes on Tuesday, March 10, 2009. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, March 10, 2009 to discuss the results of the quarter and full year and other business developments.

Interested parties may access the live conference call via telephone by dialing (800) 366-8058 U.S. or (303) 262-2190 (International), or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Tuesday, March 10, 2009 through Tuesday, March 17, 2009 by dialing (800) 405-2236 (US) or (303) 590-3000 (International) and entering Passcode 11127343#.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at www.iridex.com.


'/>"/>
SOURCE IRIDEX
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. IRIDEX Reports Third Quarter 2008 Financial Results
2. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
3. IRIDEX Reports First Quarter 2008 Financial Results
4. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
5. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
6. IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
7. IRIDEX Reports Third Quarter Financial Results
8. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
9. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
10. James B. Hawkins Appointed to IRIDEX Board of Directors
11. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...mood despite similar weight loss , , MON...ow-carbohydrate diet such as the popular Atkins pr... people lose pounds over the course of a year. ,...sult in long-term improvement in mood, according t...rnal Medicine . , People on both diets consumed...
(Date:11/9/2009)...-FirstCall/ - Hard To Treat Diseases (HTDS.PK) ww... a US$41 billion international healthcare company,...artner, Zhejiang Tianyuan Bio-Pharmaceutical Co., ...will begin a five-year, $1 billion China initiativ...rease its investment in its China R&D facility...
(Date:11/9/2009)...ffered in April 2010, Provides First Responders wi...ambridge, MA (Vocus) November 9, 2009 -- When Stef...rst inspected a suspected mass grave at Dasht-e-L...team of experts to help interpret the scene. He kn...rst step in securing evidence of a human rights vi...
(Date:11/9/2009)...swire/ -- Actress Mariska Hargitay and the Joyfu...rday to raise awareness about the need for domesti...by building healing and wellness kits for women in...e one to each of the estimated 600 women currently...tic violence shelters. ,, "Our goal is to shine...
(Date:11/9/2009)...hlighting a commitment to providing long-term heal...d digital display technology options, LG Electroni...pital Grade LCD HDTVs this week at the Association...eeting and exposition (booth #1760). ,, On disp..." Long-Term Care LCD HDTVs bring a sense of home a...
Breaking Medicine News(10 mins):Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5
...llowing is an Op-Ed,by David W. Gorman, Washington...ican Veterans:, On Veterans Day, politicians will...action in Iraq and Afghanistan as if this "statist...., That 30,000 number is a fantasy., Here,s the ...
...lth Management With Business Objectives, Watson ...vey Finds, WASHINGTON, Nov. 7 With continuing pr...s plan to offer financial,incentives to reward wor...lth, a non-profit association of 285 large,employe...
...des researchers from the University of Cincinnati ... violence-related deaths in Hamilton County, Ohio,...stic violence over that period, 94 percent of the ...a gunshot wound fired by their spouses. Forty-four...
...rance program, Seguro Popular, which was created t...n uninsured by 2010, is having a positive effect o...ountry, according to a study published in the Octo... treatment for hypertension and significantly more...
...ogists recommends regular hand washing to,decrease...ns, NORTHFIELD, Ill., Nov. 7 ,Methicillin-resista...ig,name that is suddenly causing big problems for ...espond to treatment with,common antibiotics, such ...
...of tumor types, studies find , , WEDNESDAY...1 million British women finds that overweight or o...er cases. , That,s about 6,000 out of the 120,000 ...her risk of developing and dying from cancer, incl...
Other Medicine News:Health News:Shape Shifting on Veterans Day 2Health News:More Employers to Offer Workers Financial Incentives for Healthy Behavior 2Health News:More Employers to Offer Workers Financial Incentives for Healthy Behavior 3Health News:More Employers to Offer Workers Financial Incentives for Healthy Behavior 4Health News:Researchers analyze domestic violence deaths 2Health News:Researchers analyze domestic violence deaths 3Health News:Mexico's expanded health insurance improves hypertension treatment 2Health News:Good Hygiene Is Key to Preventing MRSA 2Health News:Excess Pounds Raise Women's Cancer Risk 2Health News:Excess Pounds Raise Women's Cancer Risk 3
(Date:11/9/2009)...v. 9 Keryx Biopharmaceut...company focused on the acquisition, development an...eutical products for the treatment of life-threate...(the "Company"), today announced its results for t...t September 30, 2009, the Company had cash, cash e...
(Date:11/9/2009)...v. 9 Patent attorneys Cheryl Lilje... J. D., will showcase Stipkala LLC at the Texas Li...will be held at the Institute of Molecular Medicin...ce provides a platform for cutting-edge companies ...rs, and will feature keynote addresses and panel d...
(Date:11/9/2009)...v. 9 MISSION Skincare®, the i...Serena Williams, soccer professional Mia Hamm, and...tive Lifestyle Skincare Destinations" in the beaut...across the country beginning this week. Stocked wi...s, MISSION and CVS/pharmacy have set out to establ...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 6Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 2Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 3Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 1Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 2Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 3Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 4Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 5Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 6Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 7Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 8Pelosi Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments 53395 9BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 1BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 2Excaliard Pharmaceuticals Appoints Jay Birnbaum Ph D to the Board of Directors 53389 1Excaliard Pharmaceuticals Appoints Jay Birnbaum Ph D to the Board of Directors 53389 2
...J., March 12 Genta,Incorporated (Nasdaq: GNTA ) ... the quarter and year ended December 31, 2007. The...uding:, -- AGENDA Phase 3 trial using key bio..., G4544, completes initial Phase 1 trial; planned ...oral taxane, becomes new clinical-stage product ...
... FDA Approve Novel Anesthesia Drug to Reverse Musc..., KENILWORTH, N.J., March 11 Schering-Plough,(NY...Drug Administration,(FDA) Advisory Committee on An...dex for approval. After reviewing data on the safe...nanimously recommended approval of the,company,s a...
Other Medicine Technology:Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 2Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 3Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 4Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 5Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 6Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 7Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 8Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 9Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 10FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 2FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 3FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 4
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: